| Date Filed | Type | Description |
| 10/12/2023 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
| 08/14/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 06/05/2023 |
8-K/A
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 05/30/2023 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders... |
| 05/16/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 05/15/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 05/15/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 05/15/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/03/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 05/01/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 05/01/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 04/24/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 04/05/2023 |
S-1
| Form S-1 - General form for registration of securities under the Securities Act of 1933: |
| 03/31/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 03/31/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 03/22/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 03/13/2023 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 02/06/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/25/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 01/13/2023 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
| 12/12/2022 |
S-1
| Form S-1 - General form for registration of securities under the Securities Act of 1933: |
| 11/07/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 11/04/2022 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 11/03/2022 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 10/28/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 10/11/2022 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 10/07/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 10/06/2022 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 10/05/2022 |
S-4/A
| Form S-4/A - Registration of securities, business combinations: [Amend] |
| 10/04/2022 |
S-4/A
| Form S-4/A - Registration of securities, business combinations: [Amend] |
| 09/23/2022 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 09/23/2022 |
8-K
| Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Other Even...|
Docs:
|
"UNSECURED PROMISSORY NOTE",
"Mana Capital Acquisition Corp. Announces Intention to Further Extend Period to Consummate Initial Business Combination Dover, DE, September 22, 2022—Mana Capital Acquisition Corp. today announced that its Board of Directors has approved a second extension of the period of time available to the Company to consummate its initial business combination by one month from September 26, 2022 to October 26, 2022 , as permitted under the Company’ s amended and restated certificate of incorporation. In connection therewith, pursuant to the merger agreement, dated May 27, 2022, among the Company, Mana Merger Sub, Inc., Cardio Diagnostics, Inc. , and Meeshanthini Dogan, as representative of the shareholders of Cardio, Cardio is expected to deposit $216,667 into the trust account for the Company’ s pub...",
"Mana Capital Acquisition Corp. Confirms Second Contribution to Trust Account to Extend Time Period to Complete a Business Combination Dover, DE, September 23, 2022—Mana Capital Acquisition Corp. , a special purpose acquisition company , announced today that for the purpose of consummating its previously announced business combination with Cardio Diagnostics, Inc. , the Company has further extended the date by which it is required to complete a business combination for an additional period of one month from September 26, 2022 to October 26, 2022, and that the amount of $216,667 has been deposited into the Company’ s trust account in connection with the extension. The funds deposited into the Trust Account were provided by Cardio under the terms of the definitive Merger Agreement entered int..." |
|
| 09/21/2022 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 09/21/2022 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
|